This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Endonom Medtech Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Liman Shang: Innovator in Vascular Technology
Introduction
Liman Shang is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of medical technology, particularly in vascular devices. His innovative approach has led to the development of a unique vascular shunt stent that addresses critical needs in medical procedures.
Latest Patents
Liman Shang holds 1 patent for his invention titled "Vascular shunt stent and vascular stent." This patent describes a vascular shunt stent that includes a main body tube and at least one branch tube axially inserted into the inner lumen of the main body tube. The design features a tubular main membrane and a branch tube with a tubular branch membrane, which is accommodated within the main membrane. A first sealing film is strategically placed to separate the inner lumen into a main opening and at least one first sub-opening, ensuring effective functionality.
Career Highlights
Liman Shang is associated with Hangzhou Endonom Medtech Co., Ltd., where he applies his expertise in developing advanced medical devices. His work focuses on improving patient outcomes through innovative vascular solutions. His dedication to research and development has positioned him as a key player in the medical technology sector.
Collaborations
Liman collaborates with talented professionals in his field, including Wei Guo and Yongsheng Wang. Their combined efforts contribute to the advancement of medical technologies and the successful implementation of innovative solutions.
Conclusion
Liman Shang's contributions to vascular technology exemplify the impact of innovation in the medical field. His patented vascular shunt stent represents a significant advancement that can enhance patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile